Young Kim

Law-Enforcement Innovate to De-Escalate Act

This bill removes less-than-lethal projectile devices (e.g., certain TASERs) from regulation under the Gun Control Act.

The term less-than-lethal projectile device means a device that (1) is not designed or intended to expel (and may not be readily converted to discharge) commonly used ammunition or projectiles exceeding a velocity of 500 feet per second; (2) is designed and intended to be used in a manner not likely to cause death or serious bodily injury; and (3) does not accept (and cannot be readily modified to accept) an ammunition feeding device.

The bill also requires the Bureau of Alcohol, Tobacco, Firearms and Explosives to determine whether a device satisfies the definition of a less-than-lethal projectile device within 90 days of a request.

Radiation Oncology Case Rate Value Based Program Act of 2025 or the ROCR Value Based Program Act

This bill establishes a specialized payment program under Medicare for providers and suppliers of radiation oncology services.

Specifically, the Centers for Medicare & Medicaid Services (CMS) must establish a program under which radiation therapy providers (i.e., hospital outpatient departments) and suppliers (i.e., physician group practices and freestanding radiation therapy centers) receive payments for each episode of care provided to individuals with specified types of cancer. An episode of care means the period beginning on the day radiation therapy planning is furnished to the individual and ending (1) for individuals with bone or brain metastases, 30 days later; and (2) for individuals with other cancer types, 90 days later.

Participation in the program is mandatory for providers and suppliers that participate in Medicare, unless the provider or supplier is part of a state-based Center for Medicare & Medicaid Innovation model or qualifies for a significant hardship exemption. The CMS must set payment rates for the program based on national payment rates with specified adjustments (e.g., geographic adjustments). Providers and suppliers who provide certain transportation services for individuals under their care may receive an additional payment. Providers and suppliers must be accredited in accordance with certain standards, subject to payment reductions.

The Government Accountability Office must report on (1) implementation of the program, and (2) underserved areas that are in need of more or newer radiation therapy resources.

9/11 Responder and Survivor Health Funding Correction Act of 2025

This bill modifies the World Trade Center Health Program (WTCHP), including by updating the formula for determining the program’s annual funding amounts and authorizing mental health providers to provide certain evaluations under the program.

The WTCHP is a federal health care program (terminating in FY2090) providing responders and survivors with monitoring and treatment of certified medical conditions related to the terrorist attacks that occurred on September 11, 2001. Under current law, the program’s annual federal funding is determined based on the amount specifically appropriated in the previous fiscal year, adjusted for inflation.

The bill establishes a new federal funding formula for FY2026-FY2090 that is generally based on annual changes in the number of enrollees. The bill also increases the amounts the program may spend annually on medical research and activities relating to data collection. The bill requires the National Institute for Occupational Safety and Health (NIOSH), which administers the program, to submit a report to Congress on the program’s projected budgetary needs and expenditures.

In addition, the bill authorizes licensed mental health providers to perform initial health evaluations with respect to mental health conditions for purposes of determining eligibility under the WTCHP. NIOSH must issue regulations specifying the categories of mental health providers that may perform these activities.

Combating Illicit Xylazine Act

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Ensuring Community Access to Pharmacist Services Act

This bill provides for permanent coverage under Medicare of certain pharmacist services.

Specifically, the bill provides for permanent coverage of testing and treatment services provided by pharmacists relating to (1) COVID-19, influenza, respiratory syncytial virus (RSV), and streptococcal pharyngitis (strep throat); and (2) other public health needs in relation to a declared public health emergency. (Similar authorities were temporarily granted during the COVID-19 public health emergency.) Such services must be provided in accordance with the applicable state laws governing pharmacists' scope of practice.

Water Systems PFAS Liability Protection Act

This bill exempts specified water management entities from liability under the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA) for releases of certain perfluoroalkyl or polyfluoroalkyl substances, commonly referred to as PFAS. Specifically, the entities covered under the bill are public water systems, publicly or privately owned or operated treatment works, municipalities with a stormwater discharge permit, political subdivisions or special districts of a state that act as a wholesale water agency, and contractors performing the management or disposal activities for such entities.

Under the bill, the exemption only applies if a specified entity transports, treats, disposes of, or arranges for the transport, treatment or disposal of PFAS consistent with applicable laws and during and following the conveyance or treatment of water under federal or state law, such as through the management or disposal of biosolids consistent with the Federal Water Pollution Control Act.

Liability for damages or costs associated with the release of certain PFAS must not be precluded if an entity acted with gross negligence or willful misconduct.

This joint resolution proposes a constitutional amendment requiring the Supreme Court to consist of nine Justices.

Supporting Healthy Mothers and Infants Act of 2025

This bill modifies the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) to add requirements for supporting individuals impacted by a substance use disorder.

Specifically, the bill requires the Department of Agriculture to

• collaborate with the Department of Health and Human Services (HHS) to develop and disseminate nutrition education materials for individuals impacted by a substance use disorder, including materials for infants impacted by prenatal substance exposure and neonatal abstinence syndrome;

• conduct outreach to individuals who are potentially eligible for the WIC program and who are impacted by such a disorder; and

• make available to states through an online clearinghouse any nutrition education and training materials related to nutrition for individuals impacted by a substance use disorder or neonatal abstinence syndrome.

In addition, the nutrition education materials developed in collaboration with HHS must be included in (1) Center for Substance Abuse Prevention-developed education materials, and (2) HHS guidance on improving care for infants with neonatal abstinence syndrome and their families.

Under current law, the WIC program includes certain education related to drug abuse. This bill replaces references to drug abuse with substance use disorder.

This bill designates the facility of the United States Postal Service located at 6444 San Fernando Road in Glendale, California, as the "Paul Ignatius Post Office".

Securing Global Telecommunications Act

This bill requires the Department of State to develop and submit to Congress a strategy to promote the use of secure telecommunication infrastructure in countries other than the United States.

The State Department must also report to Congress on (1) efforts by China and Russia to advance authoritarian interests or oppose fair, industry-led processes at the International Telecommunication Union, the U.N. agency involved with setting telecommunications standards and related regulatory activities; and (2) opportunities for greater collaboration with allies and partners to promote secure information and communications technology infrastructure in countries other than the United States.

Providing Appropriate Recognition and Treatment Needed to Enhance Relations Act or the PARTNER Act

This bill authorizes the President to extend diplomatic immunities and privileges provided by the International Organizations Immunities Act, including immunity from certain lawsuits and exemption from property taxes, to specified international regional and research organizations.

Specifically, the bill authorizes the President to extend these immunities and privileges to

• the Association of Southeast Asian Nations (ASEAN), a regional organization with 10 members including Brunei, Indonesia, Singapore, and Vietnam;

• the Pacific Islands Forum, a regional organization with 18 members including Australia, Fiji, New Zealand, and Papua New Guinea;

• the Caribbean Community (CARICOM), a regional organization with 15 members and 6 associate members including Barbados, Grenada, Jamaica, and Saint Lucia; and

• the European Organization for Nuclear Research (CERN), an international research organization focused on particle physics.

The bill also authorizes the President to extend to the permanent observer mission of the African Union to the United Nations the privileges and immunities provided to permanent missions to the United Nations of member states.

US-Japan-ROK Trilateral Cooperation Act

This bill requires the Department of State to seek to enter negotiations with the governments of Japan and South Korea with the goal of establishing regular trilateral meetings (referred to as the US-Japan-ROK Inter-Parliamentary Dialogue) to facilitate closer cooperation on shared interests and values.

The bill sets forth membership requirements for a group representing the United States in such meetings. The group must be composed of not more than eight Members of Congress appointed by congressional leaders to serve for a term of two years.

The bill also sets forth guidance and requirements for meeting frequency and location, group leadership, gifts and donations, expenditures, and reports.